#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Ron Renaud Email
President & CEO . Kailera Therapeutics
Waltham,
LocationPrimary Email
How to contact Ron Renaud
Join and see Ron's contact info for free!Current Roles
Employees:
100Revenue:
$15.5MAbout
Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity and related conditions. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive results in Phase 2 trials in obesity and type 2 diabetes in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery, including oral administration. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health. The Company is based in Waltham, MA and San Diego, CA. For more information, visit www.kailera.com.Kailera Therapeutics Address
Waltham, null
United States